Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265210 · ClinicalTrials.gov registry record · NA
A Behavioral Intervention for Depression and Chronic Pain in Primary Care
A NA study of Depression and Chronic Pain, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 3
- Study locations
NCT03265210: Completed NA study of Depression and Chronic Pain, sponsored by Weill Medical College of Cornell University.
NCT03265210 is a NA study of Depression and Chronic Pain that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 73 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03265210, a NA study of Depression and Chronic Pain, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 3
- Study locations
Study Summary
Chronic pain and depression frequently co-exist in late and mid-life and contribute to increased disability, high health care costs, psychiatric comorbidity, and suicide. The investigators will recruit 60 adults from Weill Cornell Medical Associates primary care practices; participants will be randomized to either Relief (a 9 session behavioral intervention) or usual care/referral for mental health care. Research assessments are conducted with both groups at study entry (Baseline), 6, 9, and 12 weeks.
Primary Outcome
The MADRS is a 10 item questionnaire assessing severity of depression by scoring participants on mood, anxiety, sleep, concentration, appetite, and suicidal thoughts. The lowest score is 0, no depression symptoms, and the highest possible score is 60, severe depression symptoms.
Conditions Studied
Interventions
- BEHAVIORAL RELIEF
Study Locations (3)
New York
- Weill Cornell Internal Medicine Associates (WCIMA) - New York
- Iris Cantor Men's & Women's Health Centers - New York
- Irving Sherwood Wright Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2022-02-22 |
| Phase | NA |
What the finished NCT03265210 record still lists
NCT03265210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which RELIEF is the first listed.
NCT03265210 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03265210 about?
NCT03265210 is a clinical study titled "A Behavioral Intervention for Depression and Chronic Pain in Primary Care". Chronic pain and depression frequently co-exist in late and mid-life and contribute to increased disability, high health care costs, psychiatric comorbidity, and suicide. The investigators will recruit 60 adults from Weill Cornell Medical Associates primary care practices; participants will be rando...
What is the current status of trial NCT03265210?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2018-02-01. Estimated completion is 2022-02-22.
What conditions does trial NCT03265210 study?
This clinical trial studies the following conditions: Depression, Chronic Pain.
What interventions are being tested in trial NCT03265210?
The interventions under investigation include: RELIEF (BEHAVIORAL).
Who is sponsoring clinical trial NCT03265210?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03265210 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03265210's enrollment target sits among peer trials
73 397th of 679 higher than 279 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy